Regulations.gov document
Response Letter from FDA CDER to Novo Nordisk, Inc
Other · FDA-2017-P-6029 · posted Jan 5, 2018
Key facts
| Document ID | FDA-2017-P-6029-0022 |
|---|---|
| Title | Response Letter from FDA CDER to Novo Nordisk, Inc |
| Document type | Other |
| Subtype | Letter(s) |
| Agency | FDA |
| Docket | FDA-2017-P-6029 |
| Posted | Jan 5, 2018 |
| Comment period opens | Jan 5, 2018 |
At a glance
- None Pages
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: